Assay levels of transthyretin (TTR) seem to reflect the efficacy of drug therapy aimed at TTR amyloid cardiomyopathy (ATTR-CM) and so might be useful for indirectly assessing patient responses to ...
The new understanding of molecular events that drive the various forms of amyloidosis has led to the expansion of therapeutic options to prevent end-stage disease or even offer a cure, which has added ...
Healio spoke with Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, about the process of diagnosing amyloidosis, the importance of multidisciplinary care in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results